This paper is in the following e-collection/theme issue:

Non-randomized Protocols and Methods (ehealth) (568) JMIR Theme Issue: COVID-19 Special Issue (2452) Outbreak and Pandemic Preparedness and Management (1728) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1517) Infectious Diseases (non-STD/STI) (1575) Medication Adherence (84) Doctor-Patient Communication on Cancer, Prevention, and Screening (42) Personal Health Records, Patient-Accessible Electronic Health Records, Patient Portals (573) Patient-Reported Outcome Measures (PROMs) (288)

Published on in Vol 10, No 6 (2021): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25271, first published .
The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study

The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study

The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study

Authors of this article:

Fabio Efficace1 Author Orcid Image ;   Massimo Breccia2 Author Orcid Image ;   Paola Fazi1 Author Orcid Image ;   Francesco Cottone1 Author Orcid Image ;   Bernhard Holzner3, 4 Author Orcid Image ;   Marco Vignetti1 Author Orcid Image
Article Authors Cited by (4) Tweetations (5) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.